Main results of the Crack study in the Ile-de-France region - Overview

 

eisaac2b1.jpg

Memo, OFDT, 20 p.
January 2021

This overview presents the main results of a partnership between the French Monitoring Centre for Drugs and Drug Addiction (OFDT) and the French National Institute for Health and Medical Research (Inserm), the aim of which is to describe and evaluate the current crack cocaine situation in Île-de-France in order, in particular, to improve the treatment of users and, more generally, the response of the public authorities to a phenomenon that has been identified for around thirty years.

After a brief historical review, the first part of this summary is devoted to the supply and use of crack cocaine and to the various players involved, as well as to the geographical areas in which they are located. The second part addresses the organisation of the crack cocaine market in Paris and its surrounding area. Finally, the third part focuses more specifically on users, with a description of their profiles, their relationships with the settings in which they evolve and an analysis of their expectations and needs in terms of treatment and harm reduction. This summary concludes with the various public policy recommendations that emerge from this research.

Authors : Agnès Cadet-Taïrou (OFDT), Marie Jauffret-Roustide (Inserm), Michel Gandilhon (OFDT), Sayon Dambélé (Inserm), Candy Jangal (Inserm)

Download the PDF file (1,12 Mo)

 

 

 

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.